Rural-Urban Disparities in Cardiovascular Disease Mortality Among Middle-Age Men in China

2020 ◽  
Vol 32 (8) ◽  
pp. 436-439
Author(s):  
Lee Liu
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
Middle Age ◽  
Age Groups ◽  
Joinpoint Regression ◽  
Death Rates ◽  
Specific Data ◽  
Disease Mortality ◽  
Younger Age ◽  
Global Concern

Rural-urban health disparities are still poorly understood, due to a considerable gap in knowledge, while a looming heart disease and stroke epidemic in China has caused global concern. This report attempts to fill in the knowledge gaps to examine if rural-urban disparities in heart disease and stroke mortality have widened, which population cohorts have experienced the greatest mortality growth and disparities, and if rurality still matters in China. Age-specific data from 2002 to 2016 published in the China Health Yearbooks were analyzed with the Joinpoint Regression Program. The results reveal that China faces a fast growing cardiovascular disease epidemic with widening rural-urban disparities. Rural death rates have grown higher than urban rates along with fast rising rural mortality, and the fastest increasing rates are found among rural men in younger age groups. These findings inspire further research into the causes of the disparities.

The impact of smoking in elderly people

1999 ◽  
Vol 9 (3) ◽  
pp. 273-280 ◽  
Author(s):  
Norman J Vetter
Keyword(s):  
Lung Cancer ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Causes Of Death ◽  
Age Groups ◽  
The Elderly ◽  
Death Rates ◽  
Younger Age ◽  
Prevention Programmes ◽  
The Impact

Smoking has been closely implicated in many cardiovascular, lung and other diseases which are prevalent in the elderly, but most prevention programmes tend to be aimed at younger age groups.The prevention of smoking in retired people is a subject which is not yet fully researched, but there is a little information which suggests that it may be a worthwhile pursuit. Certainly, work has shown that longevity can be improved even in older people by stopping smoking. Coronary heart disease death rates for 65-74 year olds who have recently given up are similar to non-smokers. For other causes of death, especially lung cancer and bronchitis, the benefits of stopping smoking take up to five years to appear. In terms of morbidity, there are suggestions that ex-smokers move reasonably quickly towards the state of non-smokers for bone density, pulmonary function and muscle strength.

scholarly journals Long-term trends in cardiovascular disease mortality and association with respiratory disease

2015 ◽  
Vol 144 (4) ◽  
pp. 777-786 ◽  
Author(s):  
A. J. MERCER
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
Cerebrovascular Disease ◽  
Respiratory Infection ◽  
Death Rate ◽  
Circulatory Disease ◽  
Death Rates ◽  
Cardiovascular Disease Mortality ◽  
Disease Mortality ◽  
Increased Risk

SUMMARYThe recent decline in cardiovascular disease mortality in Western countries has been linked with changes in life style and treatment. This study considers periods of decline before effective medical interventions or knowledge about risk factors. Trends in annual age-standardized death rates from cerebrovascular disease, heart disease and circulatory disease, and all cardiovascular disease are reviewed for three phases, 1881–1916, 1920–1939, and 1940–2000. There was a consistent decline in the cerebrovascular disease death rate between 1891 and 2000, apart from brief increases after the two world wars. The heart disease and circulatory disease death rate was declining between 1891 and 1910 before cigarette smoking became prevalent. The early peak in cardiovascular mortality in 1891 coincided with an influenza pandemic and a peak in the death rate from bronchitis, pneumonia and influenza. There is also correspondence between short-term fluctuations in the death rates from these respiratory diseases and cardiovascular disease. This evidence of ecological association is consistent with the findings of many studies that seasonal influenza can trigger acute myocardial infarction and episodes of respiratory infection are followed by increased risk of cardiovascular events. Vaccination studies could provide more definitive evidence of the role in cardiovascular disease and mortality of influenza, other viruses, and common bacterial agents of respiratory infection.

scholarly journals A CRITICAL REVIEW OF VATIKA HRIDROGA WITH SPECIAL REFERENCE TO ISCHEMIC HEART DISEASE

2022 ◽  
Vol 12 (6) ◽  
pp. 69-72
Author(s):  
Anchal Jaiswal ◽  
Sanjay Kumar Singh ◽  
Seema Joshi
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
The Other ◽  
Ischemic Heart ◽  
Detailed Knowledge ◽  
Age Group ◽  
Disease Entity ◽  
Younger Age ◽  
Day By Day

Given increasing evidence, most deaths are due to non-communicable diseases; half of them are the cardiovascular disease. Hridaya is moolasthana of pranvavaha and rasavaha strotas. According to Acharya Sushruta, any condition that produces disturbance in the heart is Hridroga. It is classified into five types. Vataja Hridroga is characterized by Ruja in Urah Pradesha (Pain in the chest region). Vatika type seems to have conceived the disease entity correlated with ischemic heart disease. None of the other Cardiac afflictions appears to have been described under Hridroga. The prevalence rate in the younger age group is increasing day by day so, we need to know the detailed knowledge of vatika hridroga

scholarly journals Estimates of mortality rates in people with diabetes and cardiovascular disease using administrative pharmaceutical data

2019 ◽  
Vol 4 (3) ◽  
Author(s):  
Shaun Purkiss ◽  
Tessa Keegel ◽  
Hassan Vally ◽  
Dennis Wollersheim
Keyword(s):  
Cardiovascular Disease ◽  
Mortality Risk ◽  
Age Groups ◽  
Mortality Rates ◽  
World Health ◽  
Data Set ◽  
Medication Discontinuation ◽  
Disease Mortality ◽  
Health Organization

BackgroundQuantifying the mortality risk for people with diabetes is challenging because of associated comorbidities. The recording of cause specific mortality from accompanying cardiovascular disease in death certificate notifications has been considered to underestimate the overall mortality risk in persons with diabetes. Main AimDevelop a technique to quantify mortality risk from pharmaceutical administrative data and apply it to persons diagnosed with diabetes, and associated cardiovascular disease and dyslipidaemia before death. MethodsPersons with diabetes, cardiovascular disease and dyslipidaemia were identified in a publicly available Australian Pharmaceutical data set using World Health Organization anatomic therapeutic codes assigned to medications received. Diabetes associated multi-morbidity cohorts were constructed and a proxy mortality (PM) event determined from medication and service discontinuation. Estimates of mortality rates were calculated from 2004 for 10 years and compared persons with diabetes alone and associated cardiovascular disease and dyslipidemia. ResultsThis study identified 346,201 individuals within the 2004 calendar year as having received treatments for diabetes (n=51,422), dyslipidaemia (n=169,323) and cardiovascular disease including hypertension (n=280,105). Follow up was 3.3 x 106 person-years. Overall crude PM was 26.1 per 1000 person-years. PM rates were highest in persons with cardiovascular disease and diabetes in combination (47.5 per 100 person years). Statin treatments significantly improved the mortality rates in all persons with diabetes and cardiovascular disease alone and in combination over age groups >44 years (p<.001). Age specific diabetes PM rates using pharmaceutical data correlated well with Australian data from the National Diabetes Service Scheme (r=0.82) ConclusionProxy mortality events calculated from medication discontinuation in persons with chronic conditions can provide an alternative method to estimate disease mortality rates. The technique also allows the assessment of mortality risk in persons with chronic disease multi-morbidity.

scholarly journals A population-based study of cardiovascular disease mortality risk in US cancer patients

2019 ◽  
Vol 40 (48) ◽  
pp. 3889-3897 ◽  
Author(s):  
Kathleen M Sturgeon ◽  
Lei Deng ◽  
Shirley M Bluethmann ◽  
Shouhao Zhou ◽  
Daniel M Trifiletti ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
General Population ◽  
Cancer Diagnosis ◽  
Mortality Risk ◽  
First Year ◽  
Cardiovascular Disease Mortality ◽  
Disease Mortality ◽  
Cvd Mortality

Abstract Aims This observational study characterized cardiovascular disease (CVD) mortality risk for multiple cancer sites, with respect to the following: (i) continuous calendar year, (ii) age at diagnosis, and (iii) follow-up time after diagnosis. Methods and results The Surveillance, Epidemiology, and End Results program was used to compare the US general population to 3 234 256 US cancer survivors (1973–2012). Standardized mortality ratios (SMRs) were calculated using coded cause of death from CVDs (heart disease, hypertension, cerebrovascular disease, atherosclerosis, and aortic aneurysm/dissection). Analyses were adjusted by age, race, and sex. Among 28 cancer types, 1 228 328 patients (38.0%) died from cancer and 365 689 patients (11.3%) died from CVDs. Among CVDs, 76.3% of deaths were due to heart disease. In eight cancer sites, CVD mortality risk surpassed index-cancer mortality risk in at least one calendar year. Cardiovascular disease mortality risk was highest in survivors diagnosed at &lt;35 years of age. Further, CVD mortality risk is highest (SMR 3.93, 95% confidence interval 3.89–3.97) within the first year after cancer diagnosis, and CVD mortality risk remains elevated throughout follow-up compared to the general population. Conclusion The majority of deaths from CVD occur in patients diagnosed with breast, prostate, or bladder cancer. We observed that from the point of cancer diagnosis forward into survivorship cancer patients (all sites) are at elevated risk of dying from CVDs compared to the general US population. In endometrial cancer, the first year after diagnosis poses a very high risk of dying from CVDs, supporting early involvement of cardiologists in such patients.

Connectedness and disconnectedness to new and old media within different age groups

First Monday ◽  
2016 ◽  
Author(s):  
Joo-Young Jung
Keyword(s):  
Mass Media ◽  
Diffusion Of Innovation ◽  
Middle Age ◽  
Age Groups ◽  
Negative Relationship ◽  
The Internet ◽  
Age Group ◽  
Traditional Media ◽  
Diffusion Of Innovation Theory ◽  
Younger Age

Guided by diffusion of innovation theory, this study compares patterns of connectedness and disconnectedness to the Internet and traditional media within and across select age groups (20–39, 40–59, and 60 or over) by conducting a randomly sampled survey in Tokyo, Japan. The oldest age group fell behind younger age groups not only in regards to ownership and access, but also the scope and intensity of Internet connectedness. Within age groups, disparities in Internet connectedness was found in the oldest age group, while disparities in connecting to television, newspapers and radio was found in the youngest and middle age groups. Mass media connectedness was found to have a negative relationship with PC Internet connectedness in the oldest age group. Implications for the evolution of media connectedness and disconnectedness across different generations are discussed.

Sign in / Sign up

Export Citation Format

Share Document